353
Views
12
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Effects of combining contingency management with behavioral activation for smokers with depression

, &
Pages 114-121 | Received 11 Jul 2017, Accepted 06 Apr 2018, Published online: 14 Apr 2018

References

  • Abreu PR, Santos CE. 2008. Behavioral models of depression: a critique of the emphasis on positive reinforcement. Int J Behav Consult Ther. 4:130–145.
  • American Psychiatric Association (APA). 2000. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, Text Revision (Fourth Edition). Washington (DC): APA.
  • Audrain-McGovern J, Rodriguez D, Rodgers K, Cuevas J. 2011. Declining alternative reinforcers link depression to young adult smoking. Addiction. 106:178–187.
  • Banducci AN, Lejuez CW, MacPherson L. 2013. Pilot of a behavioral activation-enhanced smoking cessation program for substance users with elevated depressive symptoms in residential treatment. Addict Newslett Am Psychol Div. 50:16–20.
  • Beck AT, Steer RA, Brown GK. 1996. Manual for Beck Depression Invertory-II. San Antonio (TX): Psychological Corporation.
  • Becoña E, López-Durán A, Fernández del Río E, Martínez U. 2014. Changes in the profiles of smokers seeking cessation treatment and in its effectiveness in Galicia (Spain) 2001–10. BMC Publ Health. 14:613.
  • Brown RA, Abrantes AM, Strong DR, Niaura R, Kahler CW, Miller IW, Price LH. 2014. Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers. Nicotine Tobacco Res. 16:197–207.
  • Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, Goldstein MG, Burgess ES, Miller IW. 2001. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 69:471–480.
  • Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, Wetter DW, Schreindorfer L, McCullough JP, Dolan-Mullen P, Stotts AL, Karam-Hage M. 2010. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. J Consult Clin Psychol. 78:44–54.
  • Cuijpers P, van Stratenm AM, Warmerdam L. 2007. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev. 27:318–326.
  • Dorner TE, Trostl A, Womastek I, Groman E. 2011. Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program. Nicotine Tobacco Res. 13:1068–1075.
  • D'Souza MS, Markou A. 2011. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract. 6:4–16.
  • Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. 2010. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Exp Clin Psychopharmacol. 18:37–50.
  • Ferster CB. 1973. A functional analysis of depression. Am Psychol. 28:857–870.
  • First MB, Spitzer RL, Williams JBW, Gibbon M. 1999. Entrevista clínica estructurada para los trastornos del eje I del DSM-IV, versión clínica (SCID-I-VC). Barcelona: Masson.
  • Goodchild M, Nargis N, Tursan d'Espaignet E. 2017. Global economic cost of smoking-attributable diseases. Tob Control. 27:58–64.
  • Goodwin RD, Wall MM, Garey L, Zvolensky MJ, Dierker L, Galea S, Gbedemah M, Weinberger AH, Williams JM, Hu MC, Hasin DS. 2018. Depression among current, former, and never smokers from 2005 to 2013: The hidden role of disparities in depression in the ongoing tobacco epidemic. Drug Alcohol Depend. 173:191–199.
  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. 1991. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 86:1119–1127.
  • Hesami Z, Alvanpour A, Kashani BS, Tafti SF, Heydari GR. 2010. Severity of nicotine withdrawal symptoms after smoking cessation. Tanaffos. 9:42–47.
  • Higgins ST, Heil SH, Dumeer AM, Thomas CS, Solomon LJ, Bernstein IM. 2006. Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant women. Drug Alcohol Depend. 85:138–141.
  • Kalman D, Morissette SB, George TP. 2005. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict. 14:106–123.
  • Kapson HS, Haaga DA. 2010. Depression vulnerability moderates the effects of cognitive behavior therapy in a randomized controlled trial for smoking cessation. Behav Ther. 41:447–460.
  • Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. 2000. Smoking and mental illness: a population-based prevalence study. JAMA. 284:2606–2610.
  • Lembke A, Kenasha J, DeBattista C. 2007. Depression and smoking cessation: Does the evidence support psychiatric practice? Neuropsychiatric Dis Treat. 3:487–493.
  • Leventhal AM, Piper ME, Japuntich SJ, Baker TB, Cook JW. 2014. Anhedonia, depressed mood, and smoking cessation outcome. J Consult Clin Psychol. 82:122–129.
  • Lewinsohn P. 1974. A behavioral approach to depression. In: Friedman RJ, Katz MM, editors. Psychology of depression: contemporary theory and research. Oxford (England): John Wiley, & Sons; p. 157–185.
  • Leyro TM, Crew EE, Bryson SW, Lembke A, Bailey SR, Prochaska JJ, Killen DT, Hall SM, David SP. 2016. Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 6:e010960.
  • López AA, Skelly JM, Higgins ST. 2015. Financial incentives for smoking cessation among depression-prone pregnant and newly postpartum women: effects on smoking abstinence and depression ratings. Nicotine Tobacco Res. 17:455–462.
  • López-Nuñez C, Martínez-Loredo V, Weidberg S, Pericot-Valverde I, Secades-Villa R. 2016. Voucher-based contingency management and in-treatment behaviors in smoking cessation treatment. Int J Clin Health Psychol. 16:30–38.
  • MacPherson L, Collado A, Lejuez C, Brown RA, Tull MT. 2016. Behavioral activation treatment for smoking (BATS) in smokers with depressive symptomatology. Adv Dual Diagn. 9:85–96.
  • MacPherson L, Collado A, Ninnemann A, Hoffman E. 2017. Development of a behavioral activation-based intervention for cigarette-smoking young adults. Cogn Behav Prac. 24:101–114.
  • MacPherson L, Tull MT, Matusiewicz AK, Rodman S, Strong DR, Kahler CW, Hopko DR, Zvolensky MJ, Brown RA, Lejuez CW. 2010. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 78:55–61.
  • Martell CR, Dimidjian S, Herman-Dunn R. 2013. Behavioral activation for depression: a clinician´s guide. New York: The Guilford Press.
  • Matthews AK, Li CC, Kuhns LM, Tasker TB, Cesario JA. 2013. Results from a community-based smoking cessation treatment program for LGBT smokers. J Environ Publ Health. 2013:984508.
  • Morean ME, Kong G, Camenga DR, Cavallo DA, Carroll KM, Pittman B, Krishnan-Sarin S. 2015. Contingency management improves smoking cessation treatment outcomes among highly impulsive adolescent smokers relative to cognitive behavioral therapy. Addict Behav. 42:86–90.
  • Muñoz RF, Barrera AZ, Delucchi K, Penilla C, Torres LD, Perez-Stable EJ. 2009. International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year. Nicotine Tobacco Res. 11:1025–1034.
  • Muñoz RF, Lenert LL, Delucchi K, Stoddard J, Perez JE, Penilla C, Perez-Stable EJ. 2006. Toward evidence-based Internet interventions: a Spanish/English Web site for international smoking cessation trials. Nicotine Tobacco Res. 8:77–87.
  • Petry N. 2012. Contingency management for substance abuse treatment: a guide to implementing this evidence-based practice. New York: Taylor & Francis, LLC.
  • Reid HH, Ledgerwood DM. 2016. Depressive symptoms affect changes in nicotine withdrawal and smoking urges throughout smoking cessation treatment: preliminary results. Addict Res Theory. 24:48–53.
  • Roberts NJ, Kerr SM, Smith SMS. 2013. Behavioral interventions associated with smoking cessation in the treatment of tobacco use. Health Serv Insights. 6:79–85.
  • Rosenthal R. 1994. Parametric measures of effect size. In: Cooper H, Hedges LV, editors. The handbook of research synthesis. New York: Russell Sage Foundation; p. 231–244.
  • Secades-Villa R, García-Rodríguez O, López-Núñez C, Alonso-Pérez F, Fernández-Hermida JR. 2014. Contingency management for smoking cessation among treatment-seeking patients in a community setting. Drug Alcohol Depend. 140:63–68.
  • Secades-Villa R, González-Roz A, García-Pérez Á, Becoña E. 2017. Psychological, pharmacological, and combined smoking cessation interventions for smokers with current depression: a systematic review and meta-analysis. Plos One. 12:e0188849.
  • Secades-Villa R, Vallejo-Seco G, García-Rodríguez O, López-Núñez C, Weidberg S, González-Roz A. 2015. Contingency management for cigarette smokers with depressive symptoms. Exp Clin Psychopharmacol. 23:351–360.
  • Sonne SC, Nunes EV, Jiang H, Tyson C, Rotrosen J, Reid MS. 2010. The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. Am J Addict. 19:111–118.
  • Stead LF, Carroll AJ, Lancaster T. 2017. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 3:CD001007.
  • Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. 2014. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 348:g1151.
  • Tu YK, Gilthorpe MS. 2007. Revisiting the relation between change and initial value: a review and evaluation. Statist Med. 26:443–457.
  • van der Meer RM, Willemsen MC, Smit F, Cuijpers P, Schippers GM. 2010. Effectiveness of a mood management component as an adjunct to a telephone counselling smoking cessation intervention for smokers with a past major depression: a pragmatic randomized controlled trial. Addiction. 105:1991–1999.
  • Ward KD, Asfar T, Al Ali R, Rastam S, Weg MW, Eissenberg T, Maziak W. 2013. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction. 108:394–403.
  • Wardle MC, Vincent JN, Suchting R, Green CE, Lane SD, Schmitz JM. 2017. Anhedonia is associated with poorer outcomes in contingency management for cocaine use disorder. J Subst Abuse Treat. 72:32–39.
  • Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. 2012. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population. Addiction. 107:1847–1856.
  • Zemestani M, Davoodi I, Honarmand MM, Zargar Y, Ottaviani C. 2016. Comparative effects of group metacognitive therapy versus behavioural activation in moderately depressed students. J Mental Health. 25:479–485.
  • Zvorsky I, Skelly JM, Higgins ST. 2017. Effects of financial incentives for smoking cessation on mood and anxiety symptoms among pregnant and newly postpartum women. Nicotine Tobacco Res. 20:620–627.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.